公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2020 | Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib | CHING-YAO YANG ; WEI-YU LIAO ; CHAO-CHI HO ; KUAN-YU CHEN ; TZU-HSIU TSAI ; CHIA-LIN HSU ; Liu, Yi-Nan; KANG-YI SU ; YIH-LEONG CHANG ; CHEN-TU WU ; BIN-CHI LIAO ; Hsu, Chia-Chi; Hsu, Wei-Hsun; JIH-HSIANG LEE ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU | Oncologist | 15 | 15 | |
2024 | CD44s and CD44v8-10 isoforms confer acquired resistance to osimertinib by activating the ErbB3/STAT3 signaling pathway | Liu, Yi-Nan; Tsai, Meng-Feng; SHANG-GIN WU ; Chang, Tzu-Hua; JIN-YUAN SHIH | Life sciences | | | |
2023 | Different treatment efficacies and T790M acquisition of EGFR-TKIs on NSCLC patients with variable Del-19 subtypes of EGFR | SHANG-GIN WU ; Gow, Chien-Hung; Chen, Yi-Ling; Liu, Yi-Nan; Tsai, Meng-Feng; JIN-YUAN SHIH | International journal of cancer | 1 | 1 | |
2023 | LncRNA SLCO4A1-AS1 suppresses lung cancer progression by sequestering the TOX4-NTSR1 signaling axis | Chen, Yi-Ling; Liu, Yi-Nan; YEN-TING LIN ; Tsai, Meng-Feng; SHANG-GIN WU ; Chang, Tzu-Hua; CHIA-LANG HSU ; HUEY-DONG WU ; JIN-YUAN SHIH | Journal of biomedical science | 2 | 0 | |
2020 | miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-κB Pathway | Liu, Yi-Nan; Tsai, Meng-Feng; SHANG-GIN WU ; Chang, Tzu-Hua; TZU-HSIU TSAI ; Gow, Chien-Hung; Wang, Hsin-Yi; JIN-YUAN SHIH | Molecular therapy. Nucleic acids | 25 | 26 | |
2020 | MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process | Wang, Hsin-Yi; Liu, Yi-Nan; SHANG-GIN WU ; HSU, CHIA-LANG ; Chang, Tzu-Hua; Tsai, Meng-Feng; YEN-TING LIN ; JIN-YUAN SHIH | Cancer biomarkers : section A of Disease markers | 25 | 20 | |
2024 | miR-204 suppresses cancer stemness and enhances osimertinib sensitivity in non-small cell lung cancer by targeting CD44 | SHANG-GIN WU ; Chang, Tzu-Hua; Tsai, Meng-Feng; Liu, Yi-Nan; YEN-LIN HUANG ; Hsu, Chia-Lang; Jheng, Han-Nian; JIN-YUAN SHIH | Molecular therapy. Nucleic acids | | | |
2023 | MiR-503 pleiotropically regulates epithelial-mesenchymal transition and targets PTK7 to control lung cancer metastasis | TZU-HSIU TSAI ; Gow, Chien-Hung; Liu, Yi-Nan; Tsai, Meng-Feng; Chang, Tzu-Hua; SHANG-GIN WU ; MIN-SHU HSIEH ; KANG-YI SU ; JIN-YUAN SHIH | Cancer medicine | 0 | 0 | |
2023 | Survival outcomes and prognostic factors of lung cancer patients with the MET exon 14 skipping mutation: A single-center real-world study | Gow, Chien-Hung; MIN-SHU HSIEH ; Chen, Yi-Lin; Liu, Yi-Nan; SHANG-GIN WU ; JIN-YUAN SHIH | Frontiers in oncology | 1 | 1 | |
2013 | TW01001, a novel piperazinedione compound, induces mitotic arrest and autophagy in non-small cell lung cancer A549 cells | Chen, Mei-Chuan; CHE-MING TENG ; Chen, Chun-Han; Liu, Yi-Nan; Wang, Hui-Po; Pan, Shiow-Lin; Teng, Che-Ming | Cancer Letters | 15 | 14 | |
2017 | Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C | Chang, Tzu-Hua; Tsai M.-F.; Gow, Chien-Hung; SHANG-GIN WU ; Liu, Yi-Nan; YIH-LEONG CHANG ; SUNG-LIANG YU ; HSING-CHEN TSAI ; Lin, Shih-Wen; Chen, Yen-Wei; Kuo, Po-Yen; PAN-CHYR YANG ; JIN-YUAN SHIH | Cancer letters | 48 | 47 | |
2006 | YC-1 [3-(5'-Hydroxymethyl-2'-furyl)-1-benzyl Indazole] Inhibits Neointima Formation in Balloon-Injured Rat Carotid through Suppression of Expressions and Activities of Matrix Metalloproteinases 2 and 9 | Liu, Yi-Nan; Pan, Shiow-Lin; Peng, Chieh-Yu; Guh, Jih-Hwa; Huang, Dong-Ming; Chang, Ya-Ling; Lin, Chun-Hung; Pai, Hui-Chen; Kuo, Sheng-Chu; Lee, Fang-Yu; Teng, Che-Ming | Journal of Pharmacology and Experimental Therapeutics | | | |